Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease

Chinese Medical Journal

Volumn 117, Issue 6, 2004, Pages 828-834

  Li, Jing ^a   Zheng, Jin Ping ^a   Yuan, Jin Ping ^a   Zeng, Guang Qiao ^a   Zhong, Nan Shan ^a   Lin, Cai Yuan ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

Bacterial lysate; Bronchitis; Chronic obstructive; Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; BACTERIUM LYSATE; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; CEPHALOSPORIN DERIVATIVE; GELOMYRTOL FORTE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; MACROLIDE; MUCOLYTIC AGENT; MYRTOL; PLACEBO; PROTHEO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUSCULTATION; BACTERIUM COLONY; CHINA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPEPSIA; DYSPNEA; ERADICATION THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOSTIMULATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; OUTCOMES RESEARCH; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SPECIES DIFFERENCE; SPUTUM ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; BACTERIA; BRONCHITIS; CELL EXTRACTS; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 3242710399     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163: 1256-1276.
2. Geslin P. Beta-lactam antibiotics and multiple resistant pneumococci isolated in France (1984-1994). Med Et Hyg 1995;53:2111-2118.
3. Shen XZ, Lu Q, Ye QC, et al. Prevalence of antimicrobial resistance of Streptococcus pneumoniae in Chinese children: four hospitals surveillance. Chin Med J 2003;9:1304-1307.
4. Li JB, Ma YL, Wang ZX, et al. Klebsiella pneumoniae: epidemiology and analysis of risk factors for infections caused by resistant strains. Chin Med J 2002;8:1158-1162.
5. Lusuardi M, Capelli A, Donner CF. Lung immune defences after stimulation of gut-associated lymphoid tissue with OM-85 BV: a double-blind study in patients with chronic bronchitis. Eur Respir Rev 1996;6:182-185.
6. Mauel J. Stimulation of immuno-protective mechanisms by OM-85 BV. Respiration 1994;61:8-15.
7. Orcel B, Delclaux B, Baud M, et al. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J 1994;7:446-452.
8. Nauck M, Matthys H, Emmons LR, et al. The immunomodulators Broncho-Vaxom® and and Uro-Vaxom stimulate the bacterial killing and oxidative metabolism of polymorphonuclear leukocytes by the activation of phosphatidylinositol turnover. Int J Exp Clin Chemother 1991;4:1-11.
9. Collet JP, Shapiro P, Ernst P, et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1719-1724.
10. Donner CF. Infectious exacerbations of chronic bronchitis. Monaldi Arch Chest Dis 1999;54:4348.
11. Murphy TF, Sethi S. State of the Art. Bacterial infection in chronic obstructive pulmonary disease. Ann Rev Respir Dis 1992;146:1067-1083.
12. Bignon J, Lambre C, Delepierre F. Immunomodulation et bronchite chronique. Med Hyg 1988;46:172-181.
13. Mauel J, Pham TV, Kreis B, et al. Stimulation by a bacterial extract (Broncho-Vaxom®) of the metabolic and functional activities of murine macrophages. Int J Immunopharmacol. 1989;11:637-645.
14. Bosch A, Lucena F, Pares R, et al. Bacterial immunostimulant (Broncho-Vaxom®) versus levamisole on the Immoral immune response in mice. J Immunopharmacol. 1983;5:107-116.
15. Pessey JJ, Megas F, Arnould B, et al. Prevention of recurrent rhinopharyngitis in at-risk children in France: a cost-effectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV). Pharmacoeconomics 2003; 21:1053-1068.
16. Del-Rio-Navarro BE, Luis Sienra-Monge JJ, Berber A, et al. Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels. Allergol Immunopathol (Madr) 2003;31:7-13.
17. Schaad UB, Mutterlein R, Goffin H. Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study. Chest 2002;122:2042-2049.
18. Carmona-Ramirez MA, Alvarez-Gomez V, Berber A. Use of OM-85 BV for the prevention of acute respiratory tract infections in occupational medicine. J Int Med Res 2002;30: 325-329.
19. Cvoriscec B, Ustar M, Pardon R, et al. Oral immunotherapy of chronic bronchitis: a double-blind placebo-controlled multicentre study. Respiration 1989;55:129-135.
20. Emmerich B, Emslander HP, Pachmann K, et al. Local immunity in patients with chronic bronchitis and the effects of a bacterial extract, Broncho-Vaxom®, on T lymphocytes, gamma-interferon and secretory immunoglobulin A in bronchoalveolar lavage fluid and other variables. Respiration 1990;57:90-99.